SCHEMBL5352871

SCHEMBL5352871

CCOC(=O)C=C[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 4/20 0.57
▸ EPHA2 P29317 2/20 0.57
▸ AKR1B10 O60218 1/20 0.57
▸ AKR1B1 P15121 1/20 0.57
▸ EFNA1 P20827 1/20 0.57
▸ PSEN1 P49768 1/20 0.57
▸ PSEN2 P49810 1/20 0.57
▸ APH1B Q8WW43 1/20 0.57
▸ NCSTN Q92542 1/20 0.57
▸ APH1A Q96BI3 1/20 0.57
▸ PSENEN Q9NZ42 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ VDR P11473 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ GRIN1 Q05586 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2303738 0.89 GPBAR1 (0.57) GPBAR1EPHA2AKR1B10AKR1B1EFNA1
SCHEMBL6825583 0.85 GPBAR1 (0.60) GPBAR1EPHA2AKR1B10AKR1B1EFNA1
SCHEMBL6825588 0.85 GPBAR1 (0.60) GPBAR1EPHA2AKR1B10AKR1B1EFNA1
SCHEMBL1720094 0.85 GPBAR1 (0.63) GPBAR1EPHA2AKR1B10AKR1B1EFNA1
SCHEMBL24896972 0.85 GPBAR1 (0.63) GPBAR1EPHA2AKR1B10AKR1B1EFNA1
SCHEMBL24153315 0.85 GPBAR1 (0.59) GPBAR1AKR1B10AKR1B1MEN1KMT2A
Hydrochloric Acid SCHEMBL5320085 0.84 GPBAR1 (0.62) GPBAR1EPHA2AKR1B10AKR1B1EFNA1
SCHEMBL5395210 0.84 GPBAR1 (0.59) GPBAR1EPHA2AKR1B10AKR1B1EFNA1
SCHEMBL29773449 0.83 GPBAR1 (0.58) GPBAR1EPHA2AKR1B10AKR1B1EFNA1
SCHEMBL11416283 0.82 GPBAR1 (0.57) GPBAR1EPHA2AKR1B10AKR1B1EFNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070179100-A1 Protected monomers ALNYLAM PHARMACEUTICALS, INC. 2007-08-02 — — US disclosed
US-7235552-B1 Cholenic acid amides and pharmaceutical compositions thereof RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY, INC. (US) 2007-06-26 — — US disclosed
EP-1625138-A2 PROTECTED MONOMERS Alnylam Pharmaceuticals Inc. (US) 2006-02-15 — — EP disclosed
CN-1177860-C Cholenic acid amide and its medicinal composition ҽѧ�뻯ѧ�о��� 2004-12-01 — — CN disclosed
WO-2004094345-A2 PROTECTED MONOMERS ALNYLAM PHARMACEUTICALS INC. (US) 2004-11-04 — — WO disclosed
CN-1292797-A Cholenic acid amide and its medicinal composition RES INST MEDICINE CHEM (US) 2001-04-25 — — CN disclosed
EP-1060188-A1 CHOLENIC ACID AMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) 2000-12-20 — — EP disclosed
WO-1999045024-A1 CHOLENIC ACID AMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) 1999-09-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179100-A1 Protected monomers PCNA, POLN, PARP1 GPBAR1 4124/4885EPHA2 4592/4885AKR1B10 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback